AbstractAs BRCA1 expression is often suppressed in sporadic ovarian carcinoma we characterized the regulation of the 231nt proximal ‘L6’ fragment of the BRCA1 promoter in two human ovarian surface epithelial cell and two sporadic ovarian carcinoma cell lines. Two individual regulatory elements within L6, the ‘RIBS’ element and the potential ‘CRE’ element were each necessary, but alone not sufficient for L6 activation in all four cell lines. The latter element showed some affinity for the CREB transcription factor, but cAMP pathway stimulation failed to promote its activation. This element did, however, interact with, and was activated by, c-Jun and Fra2 which suggests that it can interact with AP1-like transcription factors and that it may ...
AbstractThe mechanisms regulating expression of breast cancer 1 (BRCA1) are not fully characterised....
Ovarian cancer is the most lethal cause of death from gynecological malignancies in the Western worl...
Familial history remains the strongest risk factor for developing ovarian cancer (OC) and is associa...
AbstractAs BRCA1 expression is often suppressed in sporadic ovarian carcinoma we characterized the r...
ReducedBRCA1 gene expression is common in the sporadic form of ovarian carcinoma. The spread of this...
Since the majority of high-grade breast cancers express reduced levels of BRCA1 mRNA, we investigate...
Follistatin (FST), a folliculogenesis regulating protein, is found in relatively high concentrations...
Mutations within the BRCA1 tumor suppressor gene occur frequently in familial epithelial ovarian car...
INTRODUCTION:Increased estrogen level has been regarded to be a risk factor for breast cancer. Howev...
The mechanisms regulating expression of breast cancer 1 (BRCA1) are not fully characterised. fly stu...
The brca2 gene encodes a nuclear protein which is mainly involved in DNA repair and, when mutated, i...
AbstrAct Aromatase is the rate-limiting enzyme in estrogen biosynthesis and a key target in breast c...
The 85-kb breast cancer-associated gene BRCA1 is an established tumor suppressor gene, but its regul...
The 85-kb breast cancer-associated gene BRCA1 is an established tumor suppressor gene, but its regul...
Increasing evidence continues to emerge supporting the early hypothesis that BRCA1 might be involved...
AbstractThe mechanisms regulating expression of breast cancer 1 (BRCA1) are not fully characterised....
Ovarian cancer is the most lethal cause of death from gynecological malignancies in the Western worl...
Familial history remains the strongest risk factor for developing ovarian cancer (OC) and is associa...
AbstractAs BRCA1 expression is often suppressed in sporadic ovarian carcinoma we characterized the r...
ReducedBRCA1 gene expression is common in the sporadic form of ovarian carcinoma. The spread of this...
Since the majority of high-grade breast cancers express reduced levels of BRCA1 mRNA, we investigate...
Follistatin (FST), a folliculogenesis regulating protein, is found in relatively high concentrations...
Mutations within the BRCA1 tumor suppressor gene occur frequently in familial epithelial ovarian car...
INTRODUCTION:Increased estrogen level has been regarded to be a risk factor for breast cancer. Howev...
The mechanisms regulating expression of breast cancer 1 (BRCA1) are not fully characterised. fly stu...
The brca2 gene encodes a nuclear protein which is mainly involved in DNA repair and, when mutated, i...
AbstrAct Aromatase is the rate-limiting enzyme in estrogen biosynthesis and a key target in breast c...
The 85-kb breast cancer-associated gene BRCA1 is an established tumor suppressor gene, but its regul...
The 85-kb breast cancer-associated gene BRCA1 is an established tumor suppressor gene, but its regul...
Increasing evidence continues to emerge supporting the early hypothesis that BRCA1 might be involved...
AbstractThe mechanisms regulating expression of breast cancer 1 (BRCA1) are not fully characterised....
Ovarian cancer is the most lethal cause of death from gynecological malignancies in the Western worl...
Familial history remains the strongest risk factor for developing ovarian cancer (OC) and is associa...